Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionprotein-macromolecule adaptor activity

AKAP6 IRF2BP2 NMNAT2 RIPK3 MAGED1 YBX1 TBL1Y ICE1 BCL9 NUFIP1 KMT2D SHANK2 NFE2L2 KDM2B MYOCD TAF12 HCFC1 MED12 EP300 CUX1

6.11e-0711609720GO:0030674
GeneOntologyMolecularFunctionmolecular adaptor activity

AKAP6 IRF2BP2 NMNAT2 RIPK3 MAGED1 YBX1 TBL1Y ICE1 BCL9 NUFIP1 KMT2D SHANK2 NFE2L2 KDM2B MYOCD TAF12 HCFC1 MED12 EP300 CUX1

6.67e-0613569720GO:0060090
GeneOntologyMolecularFunctiontranscription coactivator activity

RIPK3 MAGED1 BCL9 KMT2D MYOCD TAF12 HCFC1 MED12 EP300

1.68e-05303979GO:0003713
GeneOntologyMolecularFunctiontranscription coregulator activity

IRF2BP2 RIPK3 MAGED1 TBL1Y BCL9 KMT2D KDM2B MYOCD TAF12 HCFC1 MED12 EP300

1.78e-055629712GO:0003712
GeneOntologyMolecularFunctionmitogen-activated protein kinase binding

ATF7 TNIP1 MICAL2 EP300

2.44e-0535974GO:0051019
GeneOntologyMolecularFunctionchromatin binding

YBX1 TBL1Y RXRA TRIM66 SBNO1 GLI1 TAF1 HCFC1 MED12 EP300 CRAMP1 CUX1 BAHCC1

5.84e-057399713GO:0003682
GeneOntologyMolecularFunctiontranscription coactivator binding

ATF7 HIF1A RXRA EP300

1.37e-0454974GO:0001223
GeneOntologyMolecularFunctionp53 binding

HIF1A YBX1 TAF1 EP300

5.40e-0477974GO:0002039
GeneOntologyMolecularFunctiontranscription coregulator binding

ATF7 HIF1A RXRA NFE2L2 EP300

6.06e-04140975GO:0001221
GeneOntologyBiologicalProcesspositive regulation of transcription by RNA polymerase II

SOX3 ATF7 HIF1A YBX1 TBL1Y TNIP1 BCL9 RFX7 RXRA NUFIP1 HOXB5 KMT2D NFE2L2 MICAL2 GLI1 MYOCD TAF1 TAF12 HCFC1 MED12 EP300

1.53e-0613909721GO:0045944
GeneOntologyBiologicalProcesssulfur oxidation

MICAL1 MICAL2

2.19e-052972GO:0019417
GeneOntologyBiologicalProcessnegative regulation of DNA-templated transcription

SOX3 ATF7 IRF2BP2 HIF1A MAGED1 YBX1 TBL1Y RXRA TRIM66 YLPM1 KDM2B ELF2 MYOCD TAF1 MAGEC1 SAP130 HCFC1 EP300 CUX1

2.39e-0513999719GO:0045892
GeneOntologyBiologicalProcessnegative regulation of RNA biosynthetic process

SOX3 ATF7 IRF2BP2 HIF1A MAGED1 YBX1 TBL1Y RXRA TRIM66 YLPM1 KDM2B ELF2 MYOCD TAF1 MAGEC1 SAP130 HCFC1 EP300 CUX1

2.74e-0514139719GO:1902679
GeneOntologyBiologicalProcessnegative regulation of transcription by RNA polymerase II

SOX3 ATF7 IRF2BP2 HIF1A MAGED1 YBX1 RXRA YLPM1 KDM2B MYOCD TAF1 MAGEC1 SAP130 HCFC1 EP300 CUX1

3.05e-0510539716GO:0000122
GeneOntologyCellularComponentnuclear protein-containing complex

ATF7 HIF1A YBX1 TBL1Y MCM4 ICE1 BCL9 RXRA NUFIP1 KMT2D UBAP2L NFE2L2 KDM2B MYOCD SAGE1 TAF1 TAF12 SAP130 HCFC1 MED12

3.02e-0613779520GO:0140513
GeneOntologyCellularComponentchromatin

SOX3 ATF7 NCAPD3 HIF1A MAGED1 ICE1 RFX7 RXRA NUFIP1 TRIM66 HOXB5 NFE2L2 ELF2 MYOCD TAF1 TAF12 SAP130 HCFC1 EP300 CUX1

8.92e-0614809520GO:0000785
GeneOntologyCellularComponentRNA polymerase II transcription regulator complex

ATF7 HIF1A BCL9 RXRA NFE2L2 MYOCD TAF1 TAF12

3.39e-05272958GO:0090575
GeneOntologyCellularComponenttranscription regulator complex

ATF7 HIF1A TBL1Y BCL9 RXRA NFE2L2 MYOCD TAF1 TAF12 EP300

3.78e-045969510GO:0005667
DomainPDZ

ARHGAP23 SIPA1L3 MPDZ SHANK2 TIAM1 PALS2

7.40e-05141936PF00595
DomainPDZ

ARHGAP23 SIPA1L3 MPDZ SHANK2 TIAM1 PALS2

9.67e-05148936SM00228
Domain-

ARHGAP23 SIPA1L3 MPDZ SHANK2 TIAM1 PALS2

1.04e-041509362.30.42.10
DomainPDZ

ARHGAP23 SIPA1L3 MPDZ SHANK2 TIAM1 PALS2

1.08e-04151936PS50106
DomainPDZ

ARHGAP23 SIPA1L3 MPDZ SHANK2 TIAM1 PALS2

1.12e-04152936IPR001478
DomainFAD-bd

MICAL1 MICAL2

3.63e-046932IPR002938
DomainFAD_binding_3

MICAL1 MICAL2

3.63e-046932PF01494
DomainBROMODOMAIN_1

TRIM66 TAF1 EP300

8.21e-0437933PS00633
DomainBromodomain

TRIM66 TAF1 EP300

8.89e-0438933PF00439
DomainBROMODOMAIN_2

TRIM66 TAF1 EP300

1.11e-0341933PS50014
DomainBROMO

TRIM66 TAF1 EP300

1.19e-0342933SM00297
DomainBromodomain

TRIM66 TAF1 EP300

1.19e-0342933IPR001487
Domain-

TRIM66 TAF1 EP300

1.19e-03429331.20.920.10
DomainL27

MPDZ PALS2

1.85e-0313932SM00569
DomainL27

MPDZ PALS2

1.85e-0313932PS51022
DomainL27_dom

MPDZ PALS2

1.85e-0313932IPR004172
DomainSEA

MUC16 MUC17

2.15e-0314932SM00200
Domain-

MUC16 MUC17

2.47e-03159323.30.70.960
DomainZnf_C2H2_jaz

NUFIP1 ZNF638

5.31e-0322932IPR022755
Domainzf-C2H2_jaz

NUFIP1 ZNF638

5.31e-0322932PF12171
DomainSEA

MUC16 MUC17

5.31e-0322932PF01390
DomainSEA

MUC16 MUC17

5.80e-0323932PS50024
DomainSEA_dom

MUC16 MUC17

5.80e-0323932IPR000082
DomainZnf_FYVE_PHD

SYTL2 TRIM66 KMT2D KDM2B

6.26e-03147934IPR011011
DomainZnf_PHD-finger

TRIM66 KMT2D KDM2B

7.19e-0379933IPR019787
DomainBromodomain_CS

TAF1 EP300

7.38e-0326932IPR018359
PathwayREACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING

TBL1Y RXRA EP300

2.71e-0513663MM15622
PathwayBIOCARTA_P53HYPOXIA_PATHWAY

HIF1A TAF1 EP300

1.23e-0421663M5202
PathwayREACTOME_NFE2L2_REGULATING_INFLAMMATION_ASSOCIATED_GENES

NFE2L2 EP300

2.14e-045662M48020
PathwayREACTOME_NFE2L2_REGULATING_ER_STRESS_ASSOCIATED_GENES

NFE2L2 EP300

2.14e-045662M48023
PathwayREACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX

BCL9 KMT2D EP300

2.36e-0426663MM14793
PathwayREACTOME_REGULATION_OF_GENE_EXPRESSION_BY_HYPOXIA_INDUCIBLE_FACTOR

HIF1A EP300

3.20e-046662MM14521
PathwayWP_MECP2_AND_ASSOCIATED_RETT_SYNDROME

YBX1 SGK1 APOC2 TAF1

3.74e-0473664M39401
PathwayBIOCARTA_PPARG_PATHWAY

RXRA EP300

4.47e-047662MM1573
PathwayWP_CAMKK2_PATHWAY

TSC1 NFE2L2 EP300

4.84e-0433663M40047
PathwayBIOCARTA_PPARG_PATHWAY

RXRA EP300

5.94e-048662M22058
PathwayREACTOME_NFE2L2_REGULATING_MDR_ASSOCIATED_ENZYMES

NFE2L2 EP300

5.94e-048662M48022
PathwayREACTOME_REGULATION_OF_NFE2L2_GENE_EXPRESSION

NFE2L2 EP300

5.94e-048662M48024
PathwayREACTOME_NFE2L2_REGULATES_PENTOSE_PHOSPHATE_PATHWAY_GENES

NFE2L2 EP300

5.94e-048662M46443
PathwayREACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION

RXRA ZNF638 MED12 EP300

6.38e-0484664M1008
PathwayREACTOME_NR1H3_NR1H2_REGULATE_GENE_EXPRESSION_LINKED_TO_CHOLESTEROL_TRANSPORT_AND_EFFLUX

APOC2 RXRA EP300

6.80e-0437663M29790
PathwayREACTOME_GENE_EXPRESSION_TRANSCRIPTION

MAGED1 TBL1Y SGK1 TSC1 ICE1 RXRA KMT2D PAPOLA ELF2 TAF1 TAF12 HCFC1 EP300

7.85e-0410226613MM15436
Pubmed

Human transcription factor protein interaction networks.

IRF2BP2 EYA4 MAGED1 YBX1 TBL1Y TNIP1 BCL9 RFX7 RXRA EMSY KMT2D UBAP2L YLPM1 SEC16A ZNF638 KDM2B ELF2 TAF1 TAF12 SAP130 HCFC1 EP300 CUX1 RAI2

1.39e-121429992435140242
Pubmed

Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.

IRF2BP2 BCL9 EMSY KMT2D YLPM1 KDM2B ELF2 TAF1 SAP130 HCFC1 MED12 CUX1

1.75e-11268991233640491
Pubmed

Interaction network of human early embryonic transcription factors.

EYA4 BCL9 RFX7 EMSY KMT2D SEC16A KDM2B ELF2 TAF1 TAF12 MED12 EP300 BAHCC1

2.56e-11351991338297188
Pubmed

SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.

MPDZ TNIP1 EMSY KMT2D UBAP2L RABEP1 YLPM1 SEC16A KDM2B TAF1 SAP130 HCFC1 MED12 EP300 CUX1

4.97e-11549991538280479
Pubmed

Identification of the SOX2 Interactome by BioID Reveals EP300 as a Mediator of SOX2-dependent Squamous Differentiation and Lung Squamous Cell Carcinoma Growth.

IRF2BP2 BCL9 KMT2D KDM2B ELF2 SAP130 EP300 CUX1

1.07e-108399828794006
Pubmed

Large-scale characterization of HeLa cell nuclear phosphoproteins.

IRF2BP2 NCAPD3 MCM4 BCL9 RFX7 EMSY KMT2D MDN1 PAPOLA UBAP2L YLPM1 SEC16A ZNF638 KDM2B ELF2

5.42e-09774991515302935
Pubmed

Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.

CACNA1A MAGED1 TBL1Y SIPA1L3 MPDZ TSC1 BCL9 EMSY MDN1 SHANK2 UBAP2L RABEP1 NCAN YLPM1 SEC16A CUX1

1.39e-08963991628671696
Pubmed

Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.

ATF7 NCAPD3 EYA4 TBL1Y MCM4 TNIP1 RXRA EMSY KMT2D MDN1 GLI1 SAP130 HCFC1 EP300 CUX1

2.09e-08857991525609649
Pubmed

H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.

ATF7 NCAPD3 HIF1A EYA4 RFX7 EMSY KMT2D MDN1 NFE2L2 YLPM1 ZNF638 KDM2B ELF2 TAF12 SAP130 HCFC1 EP300 CUX1

2.40e-081294991830804502
Pubmed

MYC Protein Interactome Profiling Reveals Functionally Distinct Regions that Cooperate to Drive Tumorigenesis.

IRF2BP2 MAGED1 MCM4 EMSY SBNO1 KDM2B ELF2 TAF12 SAP130 HCFC1

4.90e-08339991030415952
Pubmed

Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism.

NCAPD3 EMSY KMT2D PAPOLA SBNO1 YLPM1 ZNF638 SAP130 HCFC1 MED12

5.18e-08341991032971831
Pubmed

Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.

AKAP6 MAGED1 SIPA1L3 NUFIP1 TRIM66 TARS3 TIAM1 SBNO1 NFE2L2 MICAL2 RABEP1 YLPM1 TAF1 PALS2 TAF12 EP300 CUX1

1.27e-071285991735914814
Pubmed

Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.

PRUNE2 ATF7 NMNAT2 HIF1A SIPA1L3 RXRA PCDHB16 SHANK2 UBAP2L MICAL2 RABEP1 ZNF638 PALS2 SAP130 EP300 CRAMP1 CUX1

9.87e-071489991728611215
Pubmed

Human ATAC Is a GCN5/PCAF-containing acetylase complex with a novel NC2-like histone fold module that interacts with the TATA-binding protein.

UBAP2L TAF12 HCFC1 EP300

1.03e-062799418838386
Pubmed

Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.

ATF7 IRF2BP2 MCM4 RXRA MDN1 PAPOLA SBNO1 YLPM1 TAF1 TAF12 SAP130 HCFC1 MED12 EP300

1.12e-061014991432416067
Pubmed

Multiprotein bridging factor-1 (MBF-1) is a cofactor for nuclear receptors that regulate lipid metabolism.

RXRA TAF1 EP300

1.24e-06899312040021
Pubmed

An atlas of combinatorial transcriptional regulation in mouse and man.

HIF1A MCM4 RXRA HOXB5 NFE2L2 GLI1 ZNF408 KDM2B ELF2 MYOCD HCFC1 ANKS3 EP300

1.28e-06877991320211142
Pubmed

N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.

IRF2BP2 MCM4 TSC1 ICE1 EMSY PAPOLA UBAP2L RABEP1 YLPM1 SEC16A ZNF638 ELF2 HCFC1

2.56e-06934991333916271
Pubmed

HIF1A employs CDK8-mediator to stimulate RNAPII elongation in response to hypoxia.

HIF1A MED12 EP300

2.65e-061099323746844
Pubmed

PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.

ATF7 IRF2BP2 NCAPD3 YBX1 MCM4 BCL9 EMSY KMT2D ELF2 SAP130 HCFC1 MED12 EP300 CUX1

2.97e-061103991434189442
Pubmed

A dual-activity topoisomerase complex regulates mRNA translation and turnover.

SIPA1L3 ICE1 BCL9 KMT2D MDN1 SHANK2 GLI1 ZNF408 SEC16A HCFC1 MED12 EP300 CRAMP1 BAHCC1

3.03e-061105991435748872
Pubmed

Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.

TNIP1 ICE1 KMT2D RABEP1 SEC16A KDM2B TAF1 MED12 CUX1

3.20e-0641899934709266
Pubmed

The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.

YBX1 MCM4 ICE1 EMSY UBAP2L YLPM1 SEC16A ZNF638 ELF2 TAF1 SAP130 HCFC1 CUX1

3.22e-06954991336373674
Pubmed

The Eyes Absent family members EYA4 and EYA1 promote PLK1 activation and successful mitosis through tyrosine dephosphorylation.

EYA4 MAGED1 BCL9 RFX7 ZWINT EP300

5.06e-0615299638360978
Pubmed

Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation.

IRF2BP2 BCL9 KMT2D GLI1 YLPM1 SEC16A ZNF638 SAP130 EP300

6.57e-0645799932344865
Pubmed

EZH2 and BCL6 Cooperate to Assemble CBX8-BCOR Complex to Repress Bivalent Promoters, Mediate Germinal Center Formation and Lymphomagenesis.

EMSY UBAP2L YLPM1 KDM2B

7.68e-064499427505670
Pubmed

O-linked N-acetylglucosamine proteomics of postsynaptic density preparations using lectin weak affinity chromatography and mass spectrometry.

EMSY SHANK2 HCFC1

7.96e-061499316452088
Pubmed

mAKAP compartmentalizes oxygen-dependent control of HIF-1alpha.

AKAP6 HIF1A

8.02e-06299219109240
Pubmed

Expression of MUC17 is regulated by HIF1α-mediated hypoxic responses and requires a methylation-free hypoxia responsible element in pancreatic cancer.

HIF1A MUC17

8.02e-06299222970168
Pubmed

Mesenchymal nuclear transcription factors in nitrofen-induced hypoplastic lung.

RXRA HOXB5

8.02e-06299212505043
Pubmed

Visualization of hypoxia-inducible factor 1α-p300 interactions in live cells by fluorescence resonance energy transfer.

HIF1A EP300

8.02e-06299223966271
Pubmed

Effects of acute hypoxia exposure with different durations on activation of Nrf2-ARE pathway in mouse skeletal muscle.

HIF1A NFE2L2

8.02e-06299230513114
Pubmed

Triptolide, a Chinese herbal extract, enhances drug sensitivity of resistant myeloid leukemia cell lines through downregulation of HIF-1α and Nrf2.

HIF1A NFE2L2

8.02e-06299223930677
Pubmed

Menadione and ethacrynic acid inhibit the hypoxia-inducible factor (HIF) pathway by disrupting HIF-1α interaction with p300.

HIF1A EP300

8.02e-06299223618863
Pubmed

Role of ATF7-TAF12 interactions in the vitamin D response hypersensitivity of osteoclast precursors in Paget's disease.

ATF7 TAF12

8.02e-06299223426901
Pubmed

Translational Activation of HIF1α by YB-1 Promotes Sarcoma Metastasis.

HIF1A YBX1

8.02e-06299225965573
Pubmed

Suppression of tumor growth by designed dimeric epidithiodiketopiperazine targeting hypoxia-inducible transcription factor complex.

HIF1A EP300

8.02e-06299223448368
Pubmed

Hydrogen sulphide induces HIF-1α and Nrf2 in THP-1 macrophages.

HIF1A NFE2L2

8.02e-06299225795259
Pubmed

The hepatitis E virus ORF3 protein stabilizes HIF-1alpha and enhances HIF-1-mediated transcriptional activity through p300/CBP.

HIF1A EP300

8.02e-06299219489936
Pubmed

In vivo modulation of hypoxia-inducible signaling by topographical helix mimetics.

HIF1A EP300

8.02e-06299224821806
Pubmed

RXRα inhibits the NRF2-ARE signaling pathway through a direct interaction with the Neh7 domain of NRF2.

RXRA NFE2L2

8.02e-06299223612120
Pubmed

MCM4 potentiates evasion of hepatocellular carcinoma from sorafenib-induced ferroptosis through Nrf2 signaling pathway.

MCM4 NFE2L2

8.02e-06299239276458
Pubmed

Hypoxia-inducible factor 1a is a Tsc1-regulated survival factor in newborn neurons in tuberous sclerosis complex.

HIF1A TSC1

8.02e-06299223349360
Pubmed

Expression of HIF1α in intestinal epithelium restricts arthritis inflammation by inhibiting RIPK3-induced cell death machinery.

HIF1A RIPK3

8.02e-06299238503474
Pubmed

Exploration of the HIF-1α/p300 interface using peptide and Adhiron phage display technologies.

HIF1A EP300

8.02e-06299226135796
Pubmed

HIF-1α and Nrf2 regulates hypoxia induced overexpression of DDAH1 through promoter activation in prostate cancer.

HIF1A NFE2L2

8.02e-06299235644470
Pubmed

Direct inhibition of hypoxia-inducible transcription factor complex with designed dimeric epidithiodiketopiperazine.

HIF1A EP300

8.02e-06299220000859
Pubmed

Identification of novel NRF2-regulated genes by ChIP-Seq: influence on retinoid X receptor alpha.

RXRA NFE2L2

8.02e-06299222581777
Pubmed

NRF2 blockade suppresses colon tumor angiogenesis by inhibiting hypoxia-induced activation of HIF-1α.

HIF1A NFE2L2

8.02e-06299221278237
Pubmed

Proteasomal inhibition attenuates transcriptional activity of hypoxia-inducible factor 1 (HIF-1) via specific effect on the HIF-1alpha C-terminal activation domain.

HIF1A EP300

8.02e-06299216847340
Pubmed

Macrophage metabolic adaptation to heme detoxification involves CO-dependent activation of the pentose phosphate pathway.

HIF1A NFE2L2

8.02e-06299232556090
Pubmed

S-nitrosation of Cys-800 of HIF-1alpha protein activates its interaction with p300 and stimulates its transcriptional activity.

HIF1A EP300

8.02e-06299212914934
Pubmed

Rapamycin rescues BMP mediated midline craniosynostosis phenotype through reduction of mTOR signaling in a mouse model.

TSC1 GLI1

8.02e-06299230134066
Pubmed

Cholesterol Induces Nrf-2- and HIF-1α-Dependent Hepatocyte Proliferation and Liver Regeneration to Ameliorate Bile Acid Toxicity in Mouse Models of NASH and Fibrosis.

HIF1A NFE2L2

8.02e-06299232566088
Pubmed

Carboxyl-terminal transactivation activity of hypoxia-inducible factor 1 alpha is governed by a von Hippel-Lindau protein-independent, hydroxylation-regulated association with p300/CBP.

HIF1A EP300

8.02e-06299211940656
Pubmed

HIF-1α activates hypoxia-induced BCL-9 expression in human colorectal cancer cells.

HIF1A BCL9

8.02e-06299227121066
Pubmed

Overactivated NRF2 induces pseudohypoxia in hepatocellular carcinoma by stabilizing HIF-1α.

HIF1A NFE2L2

8.02e-06299236460215
Pubmed

Inhibition of VEGF transcription through blockade of the hypoxia inducible factor-1α-p300 interaction by a small molecule.

HIF1A EP300

8.02e-06299222789427
Pubmed

Nrf2 deficiency aggravates PM2.5-induced cardiomyopathy by enhancing oxidative stress, fibrosis and inflammation via RIPK3-regulated mitochondrial disorder.

RIPK3 NFE2L2

8.02e-06299232182211
Pubmed

Hypoxia-inducible factor 1α induces osteo/odontoblast differentiation of human dental pulp stem cells via Wnt/β-catenin transcriptional cofactor BCL9.

HIF1A BCL9

8.02e-06299235027586
Pubmed

NRF2 facilitates breast cancer cell growth via HIF1ɑ-mediated metabolic reprogramming.

HIF1A NFE2L2

8.02e-06299229275212
Pubmed

Differential regulation of actin microfilaments by human MICAL proteins.

MICAL1 MICAL2

8.02e-06299222331357
Pubmed

Serum- and glucocorticoid-induced protein kinase 1 (SGK1) increases the cystic fibrosis transmembrane conductance regulator (CFTR) in airway epithelial cells by phosphorylating Shank2E protein.

SGK1 SHANK2

8.02e-06299224811177
Pubmed

Scutellarin inhibits high glucose-induced and hypoxia-mimetic agent-induced angiogenic effects in human retinal endothelial cells through reactive oxygen species/hypoxia-inducible factor-1α/vascular endothelial growth factor pathway.

HIF1A EP300

8.02e-06299225192544
Pubmed

Identification of a functional antioxidant response element at the HIF1A locus.

HIF1A NFE2L2

8.02e-06299230241031
Pubmed

Molecular mechanism of hypoxia-inducible factor 1alpha -p300 interaction. A leucine-rich interface regulated by a single cysteine.

HIF1A EP300

8.02e-06299211063749
Pubmed

A census of human transcription factors: function, expression and evolution.

SOX3 ATF7 HIF1A YBX1 RFX7 RXRA HOXB5 KMT2D NFE2L2 GLI1 ELF2 CRAMP1

1.08e-05908991219274049
Pubmed

Identification of Human Neuronal Protein Complexes Reveals Biochemical Activities and Convergent Mechanisms of Action in Autism Spectrum Disorders.

MAGED1 MCM4 UBAP2L SEC16A CUX1

1.08e-0510199526949739
Pubmed

ALS/FTD-causing mutation in cyclin F causes the dysregulation of SFPQ.

MAGED1 YBX1 SIPA1L3 ZWINT MDN1 PAPOLA UBAP2L ZNF638 HCFC1 MED12

1.20e-05624991033729478
Pubmed

Prediction of the coding sequences of unidentified human genes. VII. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.

AKAP6 PRUNE2 TRIM66 MDN1 SEC16A

1.24e-051049959205841
Pubmed

Identification and functional characterization of transcriptional activators in human cells.

KMT2D SEC16A KDM2B TAF1 EP300 CUX1 RAI2 BAHCC1

1.89e-0539899835016035
Pubmed

New nomenclature for chromatin-modifying enzymes.

KMT2D KDM2B TAF1 EP300

2.17e-055799418022353
Pubmed

Structural basis for recruitment of CBP/p300 by hypoxia-inducible factor-1 alpha.

HIF1A EP300

2.40e-05399211959990
Pubmed

Thyroid hormone induces erythropoietin gene expression through augmented accumulation of hypoxia-inducible factor-1.

HIF1A EP300

2.40e-05399215155277
Pubmed

Acetylation of Nrf2 by p300/CBP augments promoter-specific DNA binding of Nrf2 during the antioxidant response.

NFE2L2 EP300

2.40e-05399219273602
Pubmed

Gut epithelial TSC1/mTOR controls RIPK3-dependent necroptosis in intestinal inflammation and cancer.

RIPK3 TSC1

2.40e-05399231961824
Pubmed

Two transactivation mechanisms cooperate for the bulk of HIF-1-responsive gene expression.

HIF1A EP300

2.40e-05399216237459
Pubmed

Endogenous hydrogen sulfide production is essential for dietary restriction benefits.

TSC1 NFE2L2

2.40e-05399225542313
Pubmed

Amphotericin B blunts erythropoietin response to hypoxia by reinforcing FIH-mediated repression of HIF-1.

HIF1A EP300

2.40e-05399216189267
Pubmed

The KDM6A-KMT2D-p300 axis regulates susceptibility to diverse coronaviruses by mediating viral receptor expression.

KMT2D EP300

2.40e-05399237410700
Pubmed

HIF1α protein stability is increased by acetylation at lysine 709.

HIF1A EP300

2.40e-05399222908229
Pubmed

Macrophages sensing oxidized DAMPs reprogram their metabolism to support redox homeostasis and inflammation through a TLR2-Syk-ceramide dependent mechanism.

HIF1A NFE2L2

2.40e-05399229153923
Pubmed

NF-κB suppresses HIF-1α response by competing for P300 binding.

HIF1A EP300

2.40e-05399221187066
Pubmed

NRF2 and Hypoxia-Inducible Factors: Key Players in the Redox Control of Systemic Iron Homeostasis.

HIF1A NFE2L2

2.40e-05399232791852
Pubmed

Ferroptosis as a target for protection against cardiomyopathy.

RIPK3 NFE2L2

2.40e-05399230692261
Pubmed

An essential role for p300/CBP in the cellular response to hypoxia.

HIF1A EP300

2.40e-0539928917528
Pubmed

Dual-specificity phosphatase DUSP1 protects overactivation of hypoxia-inducible factor 1 through inactivating ERK MAPK.

HIF1A EP300

2.40e-05399216081065
Pubmed

Epidithiodiketopiperazines block the interaction between hypoxia-inducible factor-1alpha (HIF-1alpha) and p300 by a zinc ejection mechanism.

HIF1A EP300

2.40e-05399219589782
Pubmed

Roles of p300 and cyclic adenosine monophosphate response element binding protein in high glucose-induced hypoxia-inducible factor 1α inactivation under hypoxic conditions.

HIF1A EP300

2.40e-05399227808477
Pubmed

Hypoxia-inducible factor (HIF) asparagine hydroxylase is identical to factor inhibiting HIF (FIH) and is related to the cupin structural family.

HIF1A EP300

2.40e-05399212042299
Pubmed

The acetyltransferase p300 regulates NRF2 stability and localization.

NFE2L2 EP300

2.40e-05399232057361
Pubmed

1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts.

RXRA EP300

2.40e-05399215647825
Pubmed

Need (more than) two to Tango: Multiple tools to adapt to changes in oxygen availability.

HIF1A NFE2L2

2.40e-05399229485192
Pubmed

Role of the C-terminal alpha-helical domain of the von Hippel-Lindau protein in its E3 ubiquitin ligase activity.

HIF1A EP300

2.40e-05399214691445
Pubmed

Genetic mutations associated with lung cancer metastasis to the brain.

NFE2L2 EP300

2.40e-05399229474635
Pubmed

EAF2 suppresses hypoxia-induced factor 1α transcriptional activity by disrupting its interaction with coactivator CBP/p300.

HIF1A EP300

2.40e-05399224421387
Pubmed

A novel mode of action of YC-1 in HIF inhibition: stimulation of FIH-dependent p300 dissociation from HIF-1{alpha}.

HIF1A EP300

2.40e-05399219074848
Pubmed

Host cell factor-1 interacts with and antagonizes transactivation by the cell cycle regulatory factor Miz-1.

HCFC1 EP300

2.40e-05399212244100
Pubmed

MiR-125b attenuates retinal pigment epithelium oxidative damage via targeting Nrf2/HIF-1α signal pathway.

HIF1A NFE2L2

2.40e-05399234875217
Pubmed

Determination of HIF-1α degradation pathways via modulation of the propionyl mark.

HIF1A EP300

2.40e-05399236789561
InteractionASF1A interactions

IRF2BP2 MCM4 TNIP1 EMSY KMT2D ELF2 TAF1 SAP130 HCFC1 EP300 CUX1

2.87e-082499611int:ASF1A
InteractionETV4 interactions

HIF1A BCL9 KMT2D NFE2L2 SEC16A KDM2B EP300

3.78e-0869967int:ETV4
InteractionKLF15 interactions

BCL9 EMSY KMT2D GLI1 SEC16A ZNF638 KDM2B TAF12 SAP130 EP300 RAI2

1.35e-072909611int:KLF15
InteractionKLF3 interactions

IRF2BP2 RFX7 EMSY KMT2D KDM2B ELF2 TAF1 TAF12 SAP130 EP300

1.36e-072289610int:KLF3
InteractionSP7 interactions

IRF2BP2 EYA4 BCL9 KMT2D YLPM1 ZNF638 KDM2B ELF2 SAP130 EP300 CUX1

2.17e-073049611int:SP7
InteractionING2 interactions

TNIP1 TARS3 ELF2 SAP130 EP300 BAHCC1

8.61e-0768966int:ING2
InteractionAR interactions

IRF2BP2 HIF1A MAGED1 BCL9 EMSY KMT2D MDN1 UBAP2L YLPM1 SEC16A KDM2B ELF2 TAF1 SAP130 HCFC1 MED12 EP300 CUX1

8.88e-079929618int:AR
InteractionPAX6 interactions

SOX3 IRF2BP2 BCL9 KMT2D CTNNA3 KDM2B ELF2 TAF1 SAP130 EP300 CUX1

1.36e-063669611int:PAX6
InteractionTBXT interactions

IRF2BP2 BCL9 KMT2D KDM2B SAP130 EP300 CUX1

1.36e-06116967int:TBXT
InteractionNFIX interactions

IRF2BP2 YBX1 EMSY KMT2D KDM2B ELF2 TAF12 SAP130 CUX1

1.38e-06227969int:NFIX
InteractionEGR2 interactions

BCL9 EMSY KMT2D SEC16A KDM2B HCFC1 EP300 BAHCC1

1.60e-06171968int:EGR2
InteractionTLX1 interactions

IRF2BP2 EYA4 BCL9 KMT2D KDM2B SAP130 EP300 CUX1

1.91e-06175968int:TLX1
InteractionALG13 interactions

PLSCR4 BCL9 TRIM66 KMT2D UBAP2L SEC16A KDM2B EP300

2.66e-06183968int:ALG13
InteractionNANOG interactions

NCAPD3 HIF1A MAGED1 MUC16 EMSY MDN1 SEC16A KDM2B SAP130 HCFC1 MED12 EP300

3.03e-064819612int:NANOG
InteractionYAP1 interactions

HIF1A YBX1 SIPA1L3 MPDZ KMT2D PAPOLA UBAP2L RABEP1 GLI1 YLPM1 SEC16A KDM2B TAF1 SAP130 HCFC1 MED12 EP300 CUX1

3.60e-0610959618int:YAP1
InteractionGSC interactions

EYA4 BCL9 KMT2D KDM2B EP300 BAHCC1

3.69e-0687966int:GSC
InteractionMYOD1 interactions

BCL9 RXRA KMT2D KDM2B MYOCD TAF12 EP300 CUX1

4.10e-06194968int:MYOD1
InteractionHDAC1 interactions

HIF1A MCM4 TNIP1 EMSY KMT2D PAPOLA NFE2L2 RABEP1 GLI1 ZNF638 KDM2B TAF1 SAP130 HCFC1 MED12 EP300 CUX1 BAHCC1

4.25e-0611089618int:HDAC1
InteractionGATA2 interactions

EYA4 BCL9 RXRA KMT2D KDM2B SAP130 EP300 CUX1

4.95e-06199968int:GATA2
InteractionHNF4A interactions

IRF2BP2 HIF1A EMSY KMT2D KDM2B ELF2 SAP130 EP300 CUX1

6.62e-06275969int:HNF4A
InteractionSOX9 interactions

BCL9 KMT2D KDM2B MED12 EP300 CUX1

6.95e-0697966int:SOX9
InteractionING1 interactions

HIF1A ZWINT ELF2 SAP130 EP300 BAHCC1

9.83e-06103966int:ING1
InteractionGATA1 interactions

PLSCR4 BCL9 KMT2D NFE2L2 ZNF638 KDM2B EP300

1.77e-05171967int:GATA1
InteractionELF4 interactions

EMSY KMT2D NFE2L2 KDM2B ELF2 TAF12

1.85e-05115966int:ELF4
InteractionTEAD1 interactions

IRF2BP2 MPDZ KMT2D KDM2B ELF2 EP300 CUX1

2.13e-05176967int:TEAD1
InteractionLHX2 interactions

BCL9 BEND2 KMT2D KDM2B ELF2 TAF12 CUX1

2.74e-05183967int:LHX2
InteractionKLF8 interactions

EMSY KMT2D SEC16A ZNF638 KDM2B ELF2 TAF12 SAP130 EP300

2.75e-05329969int:KLF8
InteractionCRX interactions

SOX3 BCL9 KMT2D CTNNA3 KDM2B MED12 EP300 BAHCC1

2.91e-05254968int:CRX
InteractionELF1 interactions

HSPBP1 EMSY NFE2L2 ELF2 TAF1 TAF12

3.10e-05126966int:ELF1
InteractionSOX4 interactions

MCM4 TSC1 SEC16A EP300 CUX1

3.12e-0576965int:SOX4
InteractionNUP35 interactions

IRF2BP2 BCL9 HOXB5 KMT2D GLI1 YLPM1 SEC16A ZNF638 SAP130 EP300

3.44e-054249610int:NUP35
InteractionHNF1B interactions

EYA4 BCL9 KMT2D KDM2B SAP130 EP300 CUX1

3.48e-05190967int:HNF1B
InteractionRPTOR interactions

HIF1A MAGED1 YBX1 SGK1 TSC1 TRIM66 UBAP2L ZNF638 EP300

3.64e-05341969int:RPTOR
InteractionKLF5 interactions

BCL9 RXRA KMT2D SEC16A KDM2B HCFC1 EP300

4.11e-05195967int:KLF5
InteractionFOSL2 interactions

ATF7 IRF2BP2 NFE2L2 EP300 BAHCC1

4.78e-0583965int:FOSL2
InteractionFEV interactions

BCL9 EMSY KMT2D KDM2B TAF1 EP300 CUX1

5.30e-05203967int:FEV
InteractionTAF3 interactions

MICAL1 ELF2 TAF1 TAF12 SAP130

6.33e-0588965int:TAF3
InteractionPPP1R13L interactions

HIF1A HSPBP1 NFE2L2 SEC16A EP300

6.33e-0588965int:PPP1R13L
InteractionELF5 interactions

TBL1Y EMSY KMT2D NFE2L2 HCFC1 EP300

7.35e-05147966int:ELF5
InteractionTLX3 interactions

HIF1A MAGED1 BCL9 KMT2D CTNNA3 KDM2B EP300 CUX1

7.58e-05291968int:TLX3
InteractionTLE3 interactions

IRF2BP2 MAGED1 BCL9 EMSY KMT2D SAGE1 SAP130 EP300 CUX1

7.73e-05376969int:TLE3
InteractionSOX10 interactions

MAGED1 BCL9 KMT2D TIAM1 EP300

7.83e-0592965int:SOX10
InteractionFOXI1 interactions

MAGED1 BCL9 KMT2D KDM2B EP300

7.83e-0592965int:FOXI1
InteractionKLF6 interactions

HIF1A EMSY NUFIP1 SEC16A TAF12

9.12e-0595965int:KLF6
InteractionSENP3 interactions

NCAPD3 HIF1A MAGED1 MCM4 KMT2D MDN1 TAF1 EP300

9.59e-05301968int:SENP3
InteractionFOXK2 interactions

TBL1Y EMSY KMT2D SAP130 HCFC1 EP300 CUX1

1.01e-04225967int:FOXK2
InteractionTAF9 interactions

EYA4 NUFIP1 GLI1 TAF1 TAF12 HCFC1

1.13e-04159966int:TAF9
InteractionFHL2 interactions

HIF1A TNIP1 EMSY ZNF408 ZNF638 SAP130 EP300 RAI2 BAHCC1

1.15e-04396969int:FHL2
InteractionSUMO2 interactions

NCAPD3 MCM4 TNIP1 MDN1 UBAP2L NFE2L2 ZNF638 TAF1 HCFC1 EP300 CUX1

1.16e-045919611int:SUMO2
InteractionTAF12 interactions

ATF7 ZWINT ELF2 TAF1 TAF12

1.16e-04100965int:TAF12
InteractionKLF4 interactions

TNIP1 BCL9 KMT2D KDM2B EP300 CUX1

1.17e-04160966int:KLF4
InteractionBUB3 interactions

YBX1 TNIP1 ZWINT KMT2D GLI1 HCFC1 EP300

1.22e-04232967int:BUB3
InteractionRCOR1 interactions

TNIP1 ICE1 TRIM66 KMT2D RABEP1 SEC16A KDM2B TAF1 MED12 CUX1

1.22e-044949610int:RCOR1
InteractionFOS interactions

ATF7 HIF1A BCL9 KMT2D NFE2L2 KDM2B TAF1 EP300

1.23e-04312968int:FOS
InteractionHDAC3 interactions

IRF2BP2 HIF1A TBL1Y RXRA PAPOLA NFE2L2 SEC16A EP300

1.26e-04313968int:HDAC3
InteractionSMG7 interactions

IRF2BP2 BCL9 TRIM66 KMT2D UBAP2L YLPM1 SEC16A KDM2B

1.43e-04319968int:SMG7
InteractionIRF2 interactions

IRF2BP2 NFE2L2 HCFC1 EP300 CUX1

1.60e-04107965int:IRF2
InteractionEN1 interactions

KMT2D KDM2B SAP130 EP300 CUX1

1.82e-04110965int:EN1
InteractionWWTR1 interactions

MPDZ TNIP1 EMSY KMT2D RABEP1 SEC16A HCFC1 EP300 CUX1

1.85e-04422969int:WWTR1
InteractionKLF16 interactions

TNIP1 EMSY KMT2D SEC16A KDM2B ELF2 TAF1 SAP130 EP300

1.95e-04425969int:KLF16
InteractionMAX interactions

HIF1A KMT2D TAF1 SAP130 HCFC1 EP300 CUX1

1.99e-04251967int:MAX
InteractionLDB1 interactions

IRF2BP2 EYA4 BCL9 TAF1 EP300

2.24e-04115965int:LDB1
InteractionGSK3B interactions

MICAL1 HIF1A YBX1 SGK1 SIPA1L3 MPDZ TSC1 RXRA NUFIP1 NFE2L2 RABEP1 SEC16A MYOCD

2.37e-048689613int:GSK3B
InteractionLHX3 interactions

BCL9 KMT2D GLI1 KDM2B TAF1 CUX1

2.58e-04185966int:LHX3
InteractionSSBP3 interactions

IRF2BP2 EYA4 YBX1 BCL9 CUX1

2.63e-04119965int:SSBP3
InteractionNCOR2 interactions

IRF2BP2 EYA4 TBL1Y RXRA NFE2L2 SEC16A EP300

2.70e-04264967int:NCOR2
InteractionASH2L interactions

ICE1 EMSY KMT2D ELF2 TAF1 HCFC1 EP300

2.76e-04265967int:ASH2L
InteractionNFIA interactions

IRF2BP2 BCL9 KMT2D KDM2B ELF2 EP300

2.81e-04188966int:NFIA
InteractionGCM1 interactions

BCL9 KMT2D KDM2B EP300

3.12e-0468964int:GCM1
InteractionPAX7 interactions

BCL9 KMT2D KDM2B SAP130 EP300

3.18e-04124965int:PAX7
InteractionFOXL1 interactions

NCAPD3 BCL9 KMT2D MDN1 KDM2B CUX1

3.52e-04196966int:FOXL1
InteractionMEN1 interactions

ATF7 NCAPD3 EMSY KMT2D MDN1 PAPOLA SBNO1 YLPM1 ZNF638 TAF1 SAP130 HCFC1 MED12 CUX1

3.59e-0410299614int:MEN1
InteractionSOX2 interactions

SOX3 IRF2BP2 MAGED1 YBX1 SIPA1L3 BCL9 KMT2D MDN1 YLPM1 SEC16A ZNF638 KDM2B ELF2 MAGEC1 SAP130 EP300 CUX1

3.65e-0414229617int:SOX2
InteractionGSK3A interactions

YBX1 SGK1 SIPA1L3 MPDZ RFX7 MDN1 SBNO1 RABEP1 SEC16A

3.71e-04464969int:GSK3A
InteractionPAX9 interactions

BCL9 KMT2D KDM2B SAP130 EP300

3.95e-04130965int:PAX9
InteractionJUN interactions

ATF7 HIF1A EYA4 HTR1A NFE2L2 KDM2B TAF1 HCFC1 EP300

4.07e-04470969int:JUN
InteractionMED15 interactions

HIF1A EYA4 UBAP2L HCFC1 MED12

4.09e-04131965int:MED15
InteractionCXXC1 interactions

KMT2D ZNF408 ELF2 HCFC1 EP300

4.24e-04132965int:CXXC1
InteractionMYB interactions

EMSY KMT2D KDM2B EP300 CUX1

4.39e-04133965int:MYB
InteractionLRRC31 interactions

NCAPD3 ICE1 TIAM1 UBAP2L SEC16A MAGEC1

4.46e-04205966int:LRRC31
InteractionCREBZF interactions

TIAM1 NFE2L2 HCFC1

4.70e-0432963int:CREBZF
InteractionPML interactions

IRF2BP2 MAGED1 RXRA EMSY TRIM66 MDN1 SBNO1 UBAP2L SEC16A ELF2 SAP130 HCFC1 EP300

4.73e-049339613int:PML
InteractionNFIC interactions

SOX3 KMT2D KDM2B ELF2 SAP130 CUX1

5.07e-04210966int:NFIC
InteractionVASP interactions

IRF2BP2 HIF1A MAGED1 SIPA1L3 MPDZ RABEP1 SEC16A

5.16e-04294967int:VASP
InteractionSOX15 interactions

EYA4 BCL9 KMT2D EP300 CUX1

5.73e-04141965int:SOX15
InteractionSUDS3 interactions

YBX1 ELF2 SAP130 HCFC1 EP300

5.73e-04141965int:SUDS3
InteractionHNF1A interactions

KMT2D KDM2B SAP130 EP300

5.80e-0480964int:HNF1A
InteractionTLX2 interactions

MCM4 BCL9 KMT2D KDM2B CUX1

5.92e-04142965int:TLX2
InteractionBCOR interactions

IRF2BP2 EYA4 EMSY TRIM66 UBAP2L SEC16A KDM2B

6.05e-04302967int:BCOR
InteractionSOX7 interactions

KMT2D KDM2B EP300 BAHCC1

6.36e-0482964int:SOX7
InteractionPPARGC1A interactions

RXRA HCFC1 MED12 EP300

6.36e-0482964int:PPARGC1A
InteractionIRF1 interactions

YBX1 NFE2L2 HCFC1 EP300

6.66e-0483964int:IRF1
InteractionNCOA1 interactions

HIF1A EYA4 SYTL2 RXRA EP300

6.71e-04146965int:NCOA1
InteractionMAFK interactions

HIF1A KMT2D NFE2L2

7.24e-0437963int:MAFK
InteractionPKP2 interactions

EYA4 TNIP1 TRIM66 RABEP1 SEC16A TAF1

7.28e-04225966int:PKP2
InteractionNAA40 interactions

IRF2BP2 MCM4 TSC1 ICE1 EMSY PAPOLA UBAP2L RABEP1 YLPM1 SEC16A ZNF638 ELF2 HCFC1

7.35e-049789613int:NAA40
InteractionCDX2 interactions

MCM4 ICE1 HCFC1 EP300

7.62e-0486964int:CDX2
InteractionCEBPA interactions

ATF7 IRF2BP2 NCAPD3 HIF1A YBX1 MCM4 BCL9 EMSY KMT2D ELF2 SAP130 HCFC1 MED12 EP300 CUX1

7.78e-0412459615int:CEBPA
CytobandXq26

SAGE1 MAGEC1

4.12e-0414992Xq26
Cytoband6q23

EYA4 SGK1

5.42e-04169926q23
GeneFamilyPDZ domain containing

ARHGAP23 SIPA1L3 MPDZ SHANK2 TIAM1 PALS2

1.10e-051526061220
GeneFamilyZinc fingers ZZ-type|Lysine acetyltransferases

TAF1 EP300

1.43e-0317602486
GeneFamilyCD molecules|Mucins

MUC16 MUC17

2.18e-0321602648
GeneFamilyAtaxins|Trinucleotide repeat containing

KMT2D MED12

3.09e-0325602775
GeneFamilyPHD finger proteins

TRIM66 KMT2D KDM2B

3.33e-039060388
ToppCell343B-Myeloid-Macrophage-FABP4+_Macrophage_proliferating_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells)

PLSCR4 NCAPD3 MCM4 ZWINT PRR19 PALS2

1.83e-06166986f4698fd08965936d51695d571bd10fb77330d916
ToppCellPrimary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

CACNA1A NMNAT2 SHANK2 MICAL2 PALS2 SRRM3

5.06e-061989864ca5ff320905ab4ff60ed90a5522227c782142a6
ToppCellLPS_IL1RA_TNF-Mesenchymal_myocytic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

AKAP6 PRUNE2 ABI3BP SYTL2 CTNNA3 MYOCD

5.36e-06200986f599e4b051ac3dad11ad437e98dc8ea6754cca53
ToppCellBronchial-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

AKAP6 PRUNE2 EYA4 MYOCD RAI2

2.70e-051599857cda111bb98f1241989e49d490bdf51a712ea589
ToppCellTCGA-Endometrium-Solid_Tissue_Normal-Endometrium_normal_tissue-Endometrium|TCGA-Endometrium / Sample_Type by Project: Shred V9

PLSCR4 PRUNE2 ABI3BP CTNNA3 MYOCD

3.71e-05170985cdc19013da7c41d1ed8400a6a643e4c684ff9912
ToppCellTCGA-Endometrium-Solid_Tissue_Normal|TCGA-Endometrium / Sample_Type by Project: Shred V9

PLSCR4 PRUNE2 ABI3BP CTNNA3 MYOCD

3.71e-051709850bde0a40440c7fdf7ba89cac8831d4014e7a4807
ToppCellTCGA-Endometrium-Solid_Tissue_Normal-Endometrium_normal_tissue|TCGA-Endometrium / Sample_Type by Project: Shred V9

PLSCR4 PRUNE2 ABI3BP CTNNA3 MYOCD

3.71e-05170985516b38c4ecf6b0b04c5d4f80c510dcc00b328c6f
ToppCelldroplet-Liver-Npc-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PLSCR4 ARHGAP23 SGK1 TIAM1 CTNNA3

3.93e-05172985a6fb1bde8d942c7b5caaf7bd14de0b7ce32fda55
ToppCellAT1-AT2_cells-HP_01|World / lung cells shred on cell class, cell subclass, sample id

EYA4 ABI3BP ARHGAP23 MICAL2 RAI2

4.26e-051759859a95ab5c361ebaa8747983c5a0d69025682a19ad
ToppCelldroplet-Liver-Npc-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PLSCR4 ARHGAP23 SGK1 TIAM1 CTNNA3

4.38e-051769853494ffa8555e6edf4b1250e10434bae9b73ec845
ToppCelldroplet-Liver-Npc-18m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PLSCR4 ARHGAP23 SGK1 TIAM1 CTNNA3

4.38e-05176985d43f6b7828b98e1dab7b726a5f99499d65a7db80
ToppCellIIH-matDC|IIH / Condition, Cell_class and T cell subcluster

PLSCR4 EYA4 ABI3BP MPDZ RAI2

4.75e-051799855999c85ce3bab5309ff1ed154be7e32b037750b1
ToppCellIIH-matDC-|IIH / Condition, Cell_class and T cell subcluster

PLSCR4 EYA4 ABI3BP MPDZ RAI2

4.75e-0517998546074b2781ed79e2979428b3ec81504621d3903c
ToppCellRA-13._Vascular_Smooth_Muscle|RA / Chamber and Cluster_Paper

AKAP6 CACNA1A PRUNE2 SYTL2 MYOCD

5.27e-05183985818fd886e0188091310825f9145fa53328f2c979
ToppCellCOVID-19-Heart-CM_4|COVID-19 / Disease (COVID-19 only), tissue and cell type

AKAP6 EYA4 F5 CTNNA3 MYOCD

5.27e-051839852902b6e8aa9a6f62bc1a792c971ab7f651a8e676
ToppCelldroplet-Lung-nan-3m-Myeloid-Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PRUNE2 IRF2BP2 SGK1 RAB44 RXRA

5.27e-05183985ec3c05b9ce1e0fbb720e0dea41f1e28fd3fd878f
ToppCellRA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper

AKAP6 CACNA1A PRUNE2 SYTL2 MYOCD

5.27e-05183985cae2ee08f985a6f005b4b8e959e465350315156a
ToppCelldroplet-Mammary_Gland-nan-18m-Mesenchymal-nan|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

AKAP6 SOX3 ABI3BP GLI1 CTNNA3

5.41e-05184985fe4d3def3da4ffdea5ae6bb059f5397efd58fef3
ToppCelldroplet-Lung-nan-3m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PRUNE2 IRF2BP2 SGK1 RAB44 RXRA

5.41e-051849853261d767d5e3d9e9fbac22ad73ca14e44beed89c
ToppCellLPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

AKAP6 PRUNE2 ABI3BP GLI1 MYOCD

5.69e-051869856add08d4ca019ff2864acdd5ec2c66a59a574591
ToppCelldroplet-Lung-nan-18m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PRUNE2 IRF2BP2 SGK1 RAB44 RXRA

5.84e-05187985f0c6e53035b00772377c4d5f761b4d11026b911a
ToppCellLA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper

AKAP6 PRUNE2 EYA4 CTNNA3 MYOCD

5.99e-051889856d249fe92d51a19da19ec14bb2262d394255d577
ToppCellLA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper

AKAP6 PRUNE2 SYTL2 MICAL2 MYOCD

5.99e-0518898534e1b074a3995aa46ab194eb45115d76d1a5514d
ToppCell10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_neural-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

AKAP6 CACNA1A HOXB5 SHANK2 SRRM3

5.99e-05188985e239bcdbd210a398a5850cb6fbf171d402f45a4f
ToppCellLPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

AKAP6 PRUNE2 ABI3BP GLI1 MYOCD

5.99e-05188985293f2fa99f5f96aa7fd2b2a5cc94ff60eeaabe11
ToppCell21-Trachea-Epithelial-Neuroendocrine|Trachea / Age, Tissue, Lineage and Cell class

CACNA1A PRUNE2 BEST3 HOXB5 SRRM3

5.99e-05188985e78d4f7a5d28c77503cb041ff585d13df4c88bd2
ToppCelldroplet-Lung-LUNG-1m-Myeloid-Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PRUNE2 IRF2BP2 SGK1 RAB44 RXRA

6.14e-05189985287e59104687fe1665232c52993889f0f2c97f17
ToppCelldroplet-Lung-1m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

PRUNE2 IRF2BP2 SGK1 RAB44 RXRA

6.14e-05189985b2542b6fcf7bc10d29158d42b03182a939ff135a
ToppCelldroplet-Lung-LUNG-1m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PRUNE2 IRF2BP2 SGK1 RAB44 RXRA

6.14e-051899856d24414ac6bd4f03f7a5ad3a6eba51d549a7b112
ToppCellLPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

PRUNE2 ABI3BP SYTL2 CTNNA3 MYOCD

6.14e-051899857ab1cfc1657277858339f7258a0c4ae9cb42fdf8
ToppCell18-Airway-Epithelial-Neuroendocrine|Airway / Age, Tissue, Lineage and Cell class

SOX3 CACNA1A PRUNE2 BEST3 F5

6.14e-05189985144beb01b908f2cd0e04513fb84d817e0c3c124e
ToppCellLA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper

AKAP6 PRUNE2 SYTL2 MICAL2 MYOCD

6.14e-051899856b3e88751b95fc2173f2c3d5061ed632d0c5f01c
ToppCelldroplet-Lung-1m-Hematologic-myeloid-alveolar_macrophage|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

PRUNE2 IRF2BP2 SGK1 RAB44 RXRA

6.30e-05190985da58227565ad6a690828dd8554dd3670222f8582
ToppCelldroplet-Heart-nan-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

AKAP6 YIPF7 TARS3 CTNNA3 MYOCD

6.45e-0519198597fb4232417a39801e87725755fd16a57c250209
ToppCelldroplet-Heart-nan-3m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

AKAP6 YIPF7 TARS3 CTNNA3 MYOCD

6.45e-0519198564070a309d7e3f6001272409ab9ce206d0e7d73f
ToppCellLPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

PRUNE2 ABI3BP SYTL2 CTNNA3 MYOCD

6.61e-05192985992d08092edbc68c47b945deb8708379738c239a
ToppCellRA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper

AKAP6 PRUNE2 NMNAT2 EYA4 CTNNA3

6.95e-0519498589812fb164065041357bb37a3c2d87028ec3de4e
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD8_EM-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

MUC16 TRIM66 SHANK2 SBNO1 MAP3K19

7.29e-051969857e98380d815fbf6254289ace2af37aac6fef51e8
ToppCellBronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

AKAP6 PRUNE2 EYA4 CTNNA3 MYOCD

7.29e-051969859830fb3da7a60f65ad463e9054bb77c06b025e4d
ToppCellE16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

ABI3BP PIK3IP1 HOXB5 MYOCD RAI2

7.65e-05198985a73534b6ca202c277a70a52281d5b97a3e6cb8ef
ToppCellsevere-HLA-DR+_CD83+_Monocyte|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

HIF1A SGK1 RXRA MUC17 MICAL2

7.65e-05198985a77f3440d7fb6a50066abc7e9ad59e83798ef13d
ToppCellSomatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

CACNA1A NMNAT2 SHANK2 MICAL2 SRRM3

7.65e-05198985c01091ef18e096d792ea2a7a715764a5b215355f
ToppCellParenchymal-NucSeq-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

CACNA1A BEST3 F5 CTNNA3 SRRM3

7.65e-051989858f25e8dff42bad8e779ca618bdb1cb1610667962
ToppCellprimary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

CACNA1A NMNAT2 SHANK2 MICAL2 SRRM3

7.65e-051989856d18b45eda4014759e6dd282d78ffd28df8a6044
ToppCellParenchymal-NucSeq-Epithelial-Epi_airway_neuro-secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

CACNA1A BEST3 F5 CTNNA3 SRRM3

7.65e-05198985e3e0aa3ef20b2370f5b133048510677aaa562dfa
ToppCellsevere-HLA-DR+_CD83+_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

HIF1A SGK1 RXRA MUC17 MICAL2

7.65e-05198985d5e525d2f2226d06a3fb985ce3a33555ff4b2e7b
ToppCellLPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

NMNAT2 ABI3BP SYTL2 MYOCD SRRM3

7.83e-051999856b3a0e5d52a30d0eed30e6a670f5b53bc233f70c
ToppCellBronchial-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

AKAP6 PRUNE2 SYTL2 CTNNA3 MYOCD

8.02e-05200985a66449b22b39dd6987fc2c3ed160d24564234ced
ToppCellNeuronal|World / cells hierarchy compared to all cells using T-Statistic

CACNA1A NMNAT2 SHANK2 MICAL2 SRRM3

8.02e-0520098548d801219bc771d6c7e151dc88ca4c179988de85
ToppCellLPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

PRUNE2 ABI3BP SYTL2 GLI1 MYOCD

8.02e-0520098508bf8c00eee6468215edb3611296bfc8784c4d56
ToppCellLPS_anti-TNF-Mesenchymal_myocytic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

PRUNE2 ABI3BP SYTL2 CTNNA3 MYOCD

8.02e-0520098567dcbd86fbc79fd585d0793f979e4aac100326c9
ToppCellLPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

AKAP6 PRUNE2 ABI3BP GLI1 MYOCD

8.02e-05200985dcdaec3ca3a3024dc1b8788c417003f84c2bffdc
ToppCellLPS_only-Mesenchymal_myocytic|LPS_only / Treatment groups by lineage, cell group, cell type

AKAP6 ABI3BP SYTL2 CTNNA3 MYOCD

8.02e-052009858bc9923f82bfb836e2f524204c92050edeae8ca5
Drugretinoic acid; Down 200; 1uM; MCF7; HT_HG-U133A

MPDZ BCL9 RXRA EMSY SHANK2 PAPOLA HCFC1 BAHCC1

1.62e-061899885208_DN
DiseaseMajor Depressive Disorder

HIF1A HTR1A ABI3BP SGK1 BCL9 MED12 CUX1

1.41e-05243957C1269683
Diseasediabetic retinopathy (implicated_via_orthology)

HIF1A NFE2L2 EP300

1.76e-0516953DOID:8947 (implicated_via_orthology)
DiseaseUnipolar Depression

HIF1A HTR1A ABI3BP SGK1 BCL9 MED12 CUX1

2.12e-05259957C0041696
DiseaseDiffuse Large B-Cell Lymphoma

SGK1 KMT2D GLI1 EP300

3.03e-0555954C0079744
Diseasecongenital heart disease (implicated_via_orthology)

RXRA KMT2D SAP130 HCFC1

7.43e-0569954DOID:1682 (implicated_via_orthology)
DiseaseBladder Neoplasm

TSC1 KMT2D GLI1 NCAN EP300

9.20e-05140955C0005695
DiseaseMalignant neoplasm of urinary bladder

TSC1 KMT2D GLI1 NCAN EP300

9.52e-05141955C0005684
DiseaseMalignant Cystosarcoma Phyllodes

KMT2D MED12

1.02e-045952C0600066
DiseasePhyllodes Tumor

KMT2D MED12

1.02e-045952C0010701
DiseaseMalignant neoplasm of breast

AKAP6 MICAL1 HIF1A YBX1 TNIP1 EMSY KMT2D SBNO1 GLI1 MED12 EP300 CUX1

1.72e-0410749512C0006142
DiseaseSquamous cell carcinoma of esophagus

HIF1A KMT2D NFE2L2 EP300

2.57e-0495954C0279626
DiseaseHeadache, glucose measurement

ZNF638 SRRM3

3.64e-049952EFO_0004468, HP_0002315
Diseaseoptic disc area measurement

ABI3BP F5 CTNNA3

4.16e-0445953EFO_0006937
Diseasemembranoproliferative glomerulonephritis (implicated_via_orthology)

F5 EP300

4.54e-0410952DOID:2920 (implicated_via_orthology)
DiseaseSquamous cell carcinoma

TSC1 TIAM1 NFE2L2 EP300

7.04e-04124954C0007137
DiseaseCarcinogenesis

NFE2L2 CUX1

7.82e-0413952C0596263
DiseaseT-Cell Lymphoma

KMT2D EP300

1.20e-0316952C0079772
Diseaseatrial fibrillation

AKAP6 EYA4 BEST3 CTNNA3 MYOCD CRAMP1

1.29e-03371956EFO_0000275
Diseasedentures

PRUNE2 MED12 BAHCC1

1.51e-0370953EFO_0010078
Diseasedental caries, dentures

PRUNE2 MED12 BAHCC1

1.51e-0370953EFO_0003819, EFO_0010078
DiseaseMammary Carcinoma, Human

HIF1A YBX1 TNIP1 EMSY KMT2D MED12 EP300

1.56e-03525957C4704874
DiseaseMammary Neoplasms, Human

HIF1A YBX1 TNIP1 EMSY KMT2D MED12 EP300

1.56e-03525957C1257931
DiseaseMammary Neoplasms

HIF1A YBX1 TNIP1 EMSY KMT2D MED12 EP300

1.59e-03527957C1458155
DiseaseEndometrial Carcinoma

NFE2L2 EP300 CUX1

1.64e-0372953C0476089
DiseaseBreast Carcinoma

HIF1A YBX1 TNIP1 EMSY KMT2D MED12 EP300

1.79e-03538957C0678222
DiseaseDepression, Bipolar

HTR1A SHANK2 NCAN

2.14e-0379953C0005587
DiseaseQRS duration, response to sulfonylurea

MDN1 ZNF638

2.48e-0323952EFO_0005055, EFO_0007922
Diseaseergothioneine measurement

CACNA1A MPDZ

3.17e-0326952EFO_0021163
DiseaseMicronuclei, Chromosome-Defective

HIF1A NFE2L2

3.17e-0326952C1449861
DiseaseMicronuclei, Genotoxicant-Induced

HIF1A NFE2L2

3.17e-0326952C1449862

Protein segments in the cluster

PeptideGeneStartEntry
TSLGNLSPDPMSSQP

BEST3

601

Q8N1M1
TPSQSHPQVMPSQSQ

ADAM29

746

Q9UKF5
PPTDMPNSQPNSQSV

CACNA1A

2051

O00555
PSQGMNVTNIPLAPS

EP300

771

Q09472
TMQTTAPGAQPEPTR

BAHCC1

1116

Q9P281
QGTQQPQQDEMPSPT

APOC2

21

P02655
SPLQQSPDVNGMAPS

CUX1

521

P39880
SPDVNGMAPSPSQSE

CUX1

526

P39880
MASGAQLPPQPSSSE

CCNI2

1

Q6ZMN8
MSQEQGPGSSTPPSS

C1orf131

11

Q8NDD1
ASGRPPMDLQPQSSD

AP5S1

71

Q9NUS5
ITQAPPSNRQMGSPT

ATF7

176

P17544
QSSMISVNPGSDEPP

CCDC60

251

Q8IWA6
PSILNPPAESQSGMA

RAI2

56

Q9Y5P3
PTQTPPTMAEQEAQP

RAB44

761

Q7Z6P3
MAQPGPASQPDVSLQ

RABEP1

1

Q15276
VTSNMSSNQDPPPAA

HCFC1

1436

P51610
MPTSPGVDLQSPAAQ

MCM4

51

P33991
GPTNIQSTPPMDNTT

MUC16

1621

Q8WXI7
GMIDGSTPTITPNPN

MDN1

2271

Q9NU22
SPLNMESEPNSPQTQ

SMCP

81

P49901
EGFPQSPLQIPMTSS

MAGEC1

401

O60732
PQSSQPPTANEMADI

MAGED1

51

Q9Y5V3
MPQIQDQTPSPSDGS

HIF1A

491

Q16665
PNSNAIPEGMREPST

BEND2

636

Q8NDZ0
MAGSSPNTPQPVPEQ

FAM104A

141

Q969W3
PTAPEQPAGEMENQT

PLSCR4

6

Q9NRQ2
GDMVQPLSPSQGQST

NFE2L2

401

Q16236
ISNPPAMINPANSDT

NCKAP1L

231

P55160
QTQLDSEGPTLPEPM

GPR152

331

Q8TDT2
GPSASSQMSALPQEP

LRRC37B

76

Q96QE4
PSNLPMPEGNSAFTQ

MED12

401

Q93074
NSMPPGLSTPTASQE

MICAL1

776

Q8TDZ2
SPQPPSITENAAMDA

GLI1

686

P08151
SQTPVDPQEGTTPLM

PIK3IP1

241

Q96FE7
TAPNMNSEPTLQPQT

MFSD6

216

Q6ZSS7
PNEQMVRNPNSSSTP

MYOCD

326

Q8IZQ8
PMATSTAAPEGQTPQ

HOXB5

161

P09067
MPFPVTTQGSQQTQP

PAPOLA

1

P51003
NDNPPQVTMSALTSP

PCDHB16

341

Q9NRJ7
SPPSSPEMNNSSINN

PALS2

106

Q9NZW5
SQGIQNMTTPPEPQA

CTNNA3

256

Q9UI47
NMTTPPEPQAATLGS

CTNNA3

261

Q9UI47
NQPGEFDTMQSPSTP

EYA4

321

O95677
SPISGMPQNENPQSR

ICE1

1331

Q9Y2F5
SPPTDNRPGQMDNRS

KDM2B

1196

Q8NHM5
PETPNTDLMQTTPQE

GFY

166

I3L273
PTVMSPSGNPQLDSK

BCL9

31

O00512
VPPSMNSQSGTIGPD

BCL9

446

O00512
SVRPAQEEQSMTPPG

CRAMP1

756

Q96RY5
MDVLSPGQGNNTTSP

HTR1A

1

P08908
SMPTQQASGQTPPRV

ELF2

511

Q15723
NVPTPEGQTPLMLAS

ANKS3

96

Q6ZW76
PQTPQSQMSLPASSE

EMSY

1071

Q7Z589
AGLATPMPTPSVQQS

SBNO1

31

A3KN83
EANMGLNPSSPNDPV

RXRA

251

P19793
RTTPPEAAQNGQSPM

IRF2BP2

411

Q7Z5L9
TPEQSMKQNEFPPVS

MAP3K19

791

Q56UN5
NAPDGSSPPQMTASE

MICAL2

1296

O94851
MPNSNPSEGTTPLTS

MUC17

1386

Q685J3
SQPMPPTAGEAEQAA

HSPBP1

101

Q9NZL4
AGAQPPPSQSQDKDM

TARS3

96

A2RTX5
PQSMENSPTINEPKD

SYTL2

431

Q9HCH5
QEQLGYAQPPSMSSP

SOX3

276

P41225
SMQSTPDAANGFPQP

SRRM3

11

A6NNA2
PETPTQEQCQDTMLP

PRUNE2

1951

Q8WUY3
SGAGNNSEPPSPTMV

TCP11X2

181

Q5H9J9
DLGQMPSPSSPTLND

F5

1486

P12259
EPASTPPQGSMANST

TAF12

21

Q16514
NAPPSNPVAMTEEQE

TAF1

1286

P21675
QQTLSPTPGDPMLAS

NCAN

426

O14594
SQPQEPELMNANPSP

SGK1

61

O00141
PGISQQVPSHPDMSQ

SATL1

201

Q86VE3
PDMSQPGMSQQVPSQ

SATL1

211

Q86VE3
SMRSIQNGQPPTSTP

SIPA1L3

116

O60292
GPDNQESTVQPMITS

ERVK-9

851

P63128
SSMEIDPQAPEPPSQ

SHANK2

1051

Q9UPX8
PNESAVPSEAAMPLQ

AKAP6

2176

Q13023
AGQENPAMSPAVSQP

NCAPD3

1301

P42695
RNPNQSSQVMDPPTA

TNIP1

606

Q15025
QQPTRPQEQSTGDTM

ZWINT

241

O95229
NMPGQLPQTLSSPST

TSC1

321

Q92574
PSEMATNSLPNGPAL

TTBK1

1006

Q5TCY1
MSPGSSDNQSSSPQP

UBAP2L

466

Q14157
MSSEAETQQPPAAPP

YBX1

1

P67809
EMNPSDQSPSPQDST

TIAM1

1011

Q13009
QSLMVPQSGSPEPES

MPDZ

1586

O75970
PSSESQPPMEAQSLP

NUFIP1

61

Q9UHK0
PVVQPPEEAMSGQQS

SEC16A

756

O15027
PQQCPGTPSSEMEQL

SEC16A

1901

O15027
GTSSDSMAQPPQTPE

RIPK3

386

Q9Y572
PQTPETSTFRNQMPS

RIPK3

396

Q9Y572
MDTQGPVSQPFQQPE

PRR19

1

A6NJB7
MQASPLQTSQPTPPE

SAGE1

1

Q9NXZ1
DNSSLGMSQPRPSPG

ARHGAP23

241

Q9P227
MPPELQSNSATQQDP

ZNF408

271

Q9H9D4
ANNLSMPTSDLPPGA

SAP130

816

Q9H0E3
EPSTVFPSANPQNMI

RFX7

1191

Q2KHR2
NSPVNMPTTGPNSLS

SYNGR4

196

O95473
AATMTPAAISQQNPP

TBL1Y

121

Q9BQ87
QQQAAPEPDPSTMTP

YLPM1

276

P49750
PEPDPSTMTPQEQQQ

YLPM1

281

P49750
AGEQPQPASFVPSEM

YIPF7

66

Q8N8F6
FTSPEMQPTTPAPQQ

ABI3BP

441

Q7Z7G0
QSIPPVSDMQPETGS

TRIM66

756

O15016
SLIPPSMNQQPFSSE

ZNF638

326

Q14966
QPSVSLGDQPGSMTQ

KMT2D

4136

O14686
SMTPVIGQPQNETPQ

NMNAT2

121

Q9BZQ4